Skip to main content
Clinical and Translational Medicine logoLink to Clinical and Translational Medicine
. 2021 Jul 16;11(7):e488. doi: 10.1002/ctm2.488

Retracted: CD248 as a novel therapeutic target in pulmonary arterial hypertension

PMCID: PMC8283842  PMID: 34323428

The following article from Clinical and Translational Medicine, “CD248 as a novel therapeutic target in pulmonary arterial hypertension” by Tao Xu, Lei Shao, Aimei Wang, Rui Liang, Yuhan Lin, GuanWang, Yan Zhao, Jing Hu, and Shuangyue Liu, 1 published online on September 17, 2020 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the authors, the journal Editor‐in‐Chief, Xiangdong Wang and John Wiley & Sons, Ltd. The retraction has been agreed due to duplicate use of figures and data in the article.

REFERENCE

  1. Xu T, Shao L, Wang A, Liang R, Lin Y, Wang G, Zhao Y, Hu J, Liu S. CD248 as a novel therapeutic target in pulmonary arterial hypertension. Clin Transl Med. 2020;10:e175. [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Clinical and Translational Medicine are provided here courtesy of John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics

RESOURCES